V2690
antibody from NSJ Bioreagents
Targeting: EPCAM
17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1
Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Immunohistochemistry [3]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2690 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- EpCAM Antibody
- Antibody type
- Monoclonal
- Antigen
- Neuraminidase treated GLS-1 human small cell lung carcinoma cells were used as the immunogen for the EpCAM antibody.
- Description
- Protein G purified antibody
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- MOC-31
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the EpCAM antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references MMTV/LTR Promoter-Driven Transgenic Expression of EpCAM Leads to the Development of Large Pancreatic Islets.
Selectins mediate small cell lung cancer systemic metastasis.
Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma.
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas.
Tufting enteropathy revisited: the utility of MOC31 (EpCAM) immunohistochemistry in diagnosis.
Vercollone JR, Balzar M, Litvinov SV, Yang W, Cirulli V
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2015 Aug;63(8):613-25
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2015 Aug;63(8):613-25
Selectins mediate small cell lung cancer systemic metastasis.
Heidemann F, Schildt A, Schmid K, Bruns OT, Riecken K, Jung C, Ittrich H, Wicklein D, Reimer R, Fehse B, Heeren J, Lüers G, Schumacher U, Heine M
PloS one 2014;9(4):e92327
PloS one 2014;9(4):e92327
Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
Skrbo N, Hjortland GO, Kristian A, Holm R, Nord S, Prasmickaite L, Engebraaten O, Mælandsmo GM, Sørlie T, Andersen K
PloS one 2014;9(11):e113278
PloS one 2014;9(11):e113278
A bispecific EpCAM/CD133-targeted toxin is effective against carcinoma.
Waldron NN, Barsky SH, Dougherty PR, Vallera DA
Targeted oncology 2014 Sep;9(3):239-49
Targeted oncology 2014 Sep;9(3):239-49
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas.
Fong D, Seeber A, Terracciano L, Kasal A, Mazzoleni G, Lehne F, Gastl G, Spizzo G
Journal of clinical pathology 2014 May;67(5):408-14
Journal of clinical pathology 2014 May;67(5):408-14
Tufting enteropathy revisited: the utility of MOC31 (EpCAM) immunohistochemistry in diagnosis.
Ranganathan S, Schmitt LA, Sindhi R
The American journal of surgical pathology 2014 Feb;38(2):265-72
The American journal of surgical pathology 2014 Feb;38(2):265-72
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of formalin-fixed, paraffin-embedded human endometrial carcinoma stained with EpCAM antibody (MOC-31).
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of formalin-fixed, paraffin-embedded human ovarian carcinoma stained with EpCAM antibody (MOC-31).
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of formalin-fixed, paraffin-embedded human colon carcinoma stained with EpCAM antibody (MOC-31).
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- SDS-PAGE Analysis of Purified, BSA-Free EpCAM Antibody (clone MOC-31). Confirmation of Integrity and Purity of the Antibody.